Waypoint swoops for Euromedic
This article was originally published in Clinica
Executive Summary
Waypoint Capital will assume full ownership of medical services provider Euromedic International after agreeing to buy shares owned by Montagu Private Equity. Waypoint was previously the majority holder of Euromedic through its investment partnership, Ares Life Sciences. Budapest, Hungary-based Euromedic is the leading provider of advanced diagnostic imaging and cancer care services in Europe, according to Waypoint, and owns and operates 144 centers across 14 countries. Euromedic has been honing its focus in these areas, and in 2011 sold its International Dialysis Centers unit to Fresenius. Euromedic services both public patients funded by National Health Funds as well as private patients funded by Private Health Insurance or by the patient directly. No financial details of the deal were given.